The meeting will bring together high-profile scientists from around the world and will focus on how basic science on rare diseases can have an impact for the development of novel therapeutic strategies. This conference will bring together a number of high profile speakers active in the field of rare disease research and translational medicine.

DEBRA International congress 2014 aims to educate participants on internationals advances in treatment and diagnoses. The informations benefits to attendees will be extensive, with opportunity to share best practices with DEBRA delegates from more 48 countries around the globe, including paediatricians, dermatologists, researchers, and other health care professionals with EB expertise.

The European Conference on Rare Diseases & Orphan Products (ECRD) promises to be an enlightening forum for rare disease stakeholders across various disciplines across in European countries. It aims to cover research, development of new treatments, healthcare, social care, information, public health and support.

This forum provides a unique opportunity to meet, network and hear from acknowledged industry experts. Discover untapped revenue streams in the blockbuster market - increase your bottom line and ensure the commercial success of your organisation. Explore the latest trends in pricing and reimbursement, and more importantly what lies beyond – from optimal business models to improving your marketing and sales strategy.

Epidermolysis Bullosa 2012, The DEBRA international Epidermolysis Bullosa Research Conference

5th November 2012

Marbella, Spain

Presentation of Alain Hovnanian and GENEGRAFT consortium: GENEGRAFT : an update on a European RDEB gene-therapy project

5th meeting of the EUCERD (European Union Committe of Experts on Rare Diseases) 19-20 June 2012Luxembourg

The European Union Committee of Experts on Rare Diseases was formally established via the European Commission Decision of 30 November 2009 (2009/872/EC) . This committee is charged with aiding the European Commission with the preparation and implementation of Community activities in the field of rare diseases.

The EUCERD holds three meetings per year at the European Commission in Luxembourg. In addition, members regularly take part in working groups and conference calls on specific topics.

The European Conference on Rare Diseases & Orphan Products is the unique platform/forum across all rare diseases, across all European countries, bringing together all stakeholders - academics, health care professionals, industry, policy makers, patients’ representatives.

It is a biennial event, providing the state-of-the-art of the rare disease environment, monitoring and benchmarking initiatives.

1st International Congress on Research of Rare and Orphan Diseases29 Feb-2 Mar 2012Basel, Switzerland

The congress will bring together world leaders and young scientist from university and industry in Stem Cells, Cell Biology, Gene Therapy, Human Genetic and Therapeutic Applications to present cutting edge research, to discuss results and to exchange ideas.

Congress goals- Promote research on rare and orphan diseases among the general public, industry and policy makers- Bring together researchers and their knowledge- Helping the understanding of other more common diseases- Encourage clear insights positions identifiable from the scientific community in university and industry

‘‘Innovation and partnerships for patients’’Initiated and organised by the Eurobiomed Competitivness Cluster and widely supported by local and national public and private partners, the Rare and Orphan Diseases Colloquium reached its objectives in 2009 by bringing together over 300 health professionals, thus making it a benchmark event in the fight against rare diseases in Europe.

Two recent workshops, sponsored by he European Commission, Health Directorate, DG Research and Innovation, and the US National Institutes of Health, Office of Rare Diseases Research (ORDR), have been held with a focus on the development of international initiatives on research of rare diseases. One of the suggested initiatives is the International Rare Diseases Research Consortium (IRDiRC). The goals of the Consortium are to deliver by 2020, 200 new therapies for rare diseases and diagnostic tests for most rare diseases. To reach these goals, utilizing available resources and adhering to coordinated research efforts are keys to success in the research of rare diseases and the development of orphan products and diagnostics.

The European Conference on Rare Diseases & Orphan Products is the unique platform/forum across all rare diseases, across all European countries, bringing together all stakeholders - academics, health care professionals, industry, policy makers, patients’ representatives.

It is a biennial event, providing the state-of-the-art of the rare disease environment, monitoring and benchmarking initiatives.